Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Intellicheck, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
3.84
3.6
4.43
7.66
10.7
16.4
16
18.9
20
22.7
Cost of revenue
0.77
0.52
0.39
1
1.43
3.51
1.28
1.38
1.83
2.17
Gross profit
3.07
3.08
4.05
6.67
9.31
12.9
14.7
17.5
18.2
20.5
Research and development
2.41
1.92
2.9
3.66
3.68
5.48
6.01
4.68
3.86
5.31
Selling, general and administrative
6.41
5.87
5.24
5.66
8.94
14.9
12.7
15.1
15.5
14.1
Operating expenses
8.82
9.16
8.14
9.32
12.6
20.4
18.7
19.8
19.3
19.4
Operating income
-5.75
-6.08
-4.09
-2.65
-3.3
-7.49
-4.03
-2.28
-1.17
1.09
Interest income
0.01
0.06
0.13
0.1
0.02
0.01
Other non-operating income
0.82
0.02
-0.01
0.23
0.28
0.25
Pre-tax income
-7.48
-4.04
-2.04
-0.89
1.33
Income tax
0
0.12
-0.06
0.03
0.06
Net income
-5.73
-6.02
-3.96
-2.55
-2.48
-7.48
-4.16
-1.98
-0.92
1.27
EBITDA
-5.32
-5.67
-3.85
-2.4
-3.12
-7.32
-3.75
-1.99
-0.73
1.79
EPS, basic
-0.64
-0.53
-0.29
-0.18
-0.15
-0.44
-0.22
-0.10
-0.05
0.07
EPS, diluted
-0.64
-0.53
-0.29
-0.18
-0.15
-0.44
-0.22
-0.10
-0.05
0.06
Shares, basic (weighted)
9.01
11.3
14.1
14.4
15.7
16.9
18.8
19.2
19.3
19.5
Shares, diluted (weighted)
9.01
11.3
14.1
14.4
15.7
16.9
18.8
19.2
19.3
20.2
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
3.09
8.01
4.38
3.35
13.1
13.7
5.2
3.98
4.67
9.65
Receivables
0.5
0.65
1.02
1.67
2.12
2.19
2.64
4.7
4.68
3.37
Inventory
0.07
0.09
0.08
0.01
Other current assets
0.17
0.22
0.27
0.35
0.34
0.64
0.61
0.69
0.57
0.89
Total current assets
3.83
8.97
5.75
5.38
15.6
16.5
13.3
14.4
9.91
13.9
Property, plant and equipment
0.27
0.21
0.26
0.18
0.14
0.74
0.75
0.67
0.54
0.39
Lease right-of-use assets
0.15
0.03
0
0
0
0
Goodwill
8.1
8.1
8.1
8.1
8.1
8.1
8.1
8.1
8.1
8.1
Intangible assets
2.15
0.46
0.31
0.17
0.48
0.38
0.27
0.58
2.37
2.08
Other non-current assets
0.06
0.07
0.01
0.01
0
0.01
0.01
0.09
0.01
0
Total assets
14.5
17.9
14.5
14
24.3
25.7
22.5
23.8
20.9
24.5
Accounts payable
0.01
0.07
0.07
0.1
0.05
0.37
0.36
0.88
0.44
0.23
Accrued liabilities
0.52
0.82
0.73
1.41
1.64
2.87
3.16
3.25
1.74
1.9
Deferred revenue
0.83
0.74
0.7
0.57
0.4
1.27
0.91
2.21
1
1.66
Total current liabilities
1.36
1.63
1.5
2.2
2.12
6.13
4.79
6.53
3.19
3.78
Lease liabilities
0.03
Total liabilities
1.6
1.87
1.54
2.25
2.13
6.13
4.79
6.53
3.19
3.78
Paid-in capital
117
126
127
129
142
146
149
151
152
154
Retained earnings
-104
-110
-114
-117
-119
-127
-132
-134
-134
-133
Shareholders' equity
12.9
16
12.9
11.7
22.2
19
17.7
17.3
17.7
20.7
Total equity
12.9
16
12.9
11.7
22.2
19
17.7
17.3
17.7
20.7
Total liabilities and equity
14.5
17.9
14.5
14
24.3
25.7
22.5
23.8
20.9
24.5
Shares outstanding
9.74
13.6
14.2
14.6
16.7
17
19
19.4
19.8
20.2
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-5.73
-6.02
-3.96
-2.55
-2.48
-7.48
-4.16
-1.98
-0.92
1.27
Depreciation and amortization
0.43
0.41
0.25
0.25
0.18
0.17
0.29
0.28
0.44
0.7
Stock-based compensation
0.94
0.44
0.19
0.58
3.45
6.4
2.46
1.6
0.88
0.78
Deferred income tax
0
0
0
0
Change in receivables
0.58
-0.15
-0.37
-0.67
-0.45
-0.07
-0.46
-2.12
-0.22
1.17
Change in inventory
0
-0.01
0
0.06
Change in payables
-0.26
0.34
-0.07
0.7
0.26
1.55
-0.26
0.62
-1.95
-0.06
Cash from operations
-4.24
-3.75
-4.22
-1.84
-0.02
1.12
-3.48
-0.65
-2.69
4.54
Capital expenditures
-0.06
-0.04
-0.14
-0.02
-0.04
-0.66
-0.19
-0.09
-0.06
-0.05
Purchases of investments
0
-4.88
Cash from investing
-0.03
0
-0.1
0.02
-0.42
-0.66
-5.07
-0.41
2.9
-0.27
Stock issued
1.78
8.51
0.69
0.09
10.6
0.05
0
0
0.31
0.9
Cash from financing
1.41
8.66
0.69
0.79
10.2
0.08
0.1
-0.16
0.49
0.71
Net change in cash
-2.86
4.92
-3.63
-1.03
9.77
0.53
-8.46
-1.22
0.69
4.98
Free cash flow
-4.3
-3.78
-4.36
-1.86
-0.06
0.45
-3.67
-0.74
-2.75
4.49
Interest paid
0
0.01
0
0.01
0
Income taxes paid
0
0.03
0.08
0
0.03
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.39 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
91.1%
Gross profit / revenue.
Operating margin
11.8%
Operating income / revenue.
EBITDA margin
13.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
13.3%
Pre-tax income / revenue.
Net margin
13.0%
Net income / revenue.
FCF margin
11.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
12.0%
Cash from operations / revenue.
Effective tax rate
1.8%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
14.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
12.3%
Net income / average total assets.
Return on invested capital (ROIC)
26.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
21.9%
Research and development expense / revenue.
SG&A / revenue
57.4%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
3.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
D&A / revenue
2.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
13.3%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
12.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
16.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
12.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
11.7%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
17.1%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
16.6%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
5.4%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-1.4%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
16.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
2.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
0.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
4.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
2.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
5.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.98x
Current assets / current liabilities.
Quick ratio
4.71x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
3.85x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
3.1%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.15
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.15
Revenue / diluted weighted shares.
FCF per share
$0.13
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.14
Cash from operations / diluted weighted shares.
Book value per share
$1.11
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
15.4x
Market cap / net income. Only when net income is positive.
P/S
2.01x
Market cap / revenue.
P/B
2.15x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.85x
Market cap / tangible book value, when positive.
P/FCF
17.2x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
16.7x
Market cap / cash from operations, when positive.
EV/Sales
1.52x
Enterprise value / revenue.
EV/EBIT
12.9x
Enterprise value / operating income, when both are positive.
EV/EBITDA
11.0x
Enterprise value / EBITDA, when both are positive.
EV/FCF
13.0x
Enterprise value / free cash flow, when both are positive.
FCF yield
5.8%
Free cash flow / market cap.
Earnings yield
6.5%
Net income / market cap (the inverse of P/E).
What was Intellicheck, Inc.'s revenue in fiscal 2025?
Intellicheck, Inc. reported revenue of $22.7M for fiscal 2025, 13.3% higher than the year before.
Was Intellicheck, Inc. profitable in fiscal 2025?
Yes. Net income was $1.3M, a net margin of 5.6%.
How much free cash flow did Intellicheck, Inc. generate in fiscal 2025?
Cash from operations of $4.5M minus capital expenditures of $52.0K left free cash flow of $4.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.